Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.45 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 75.68%. A quarter ago, it was expected that this molecular diagnostics company would post a loss of $0.50 per share when it actually produced a loss of $0.50, delivering no surprise.Over the last four quarters, the company ...